| __timestamp | Incyte Corporation | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3004000 | 5903000 |
| Thursday, January 1, 2015 | 26972000 | 2762000 |
| Friday, January 1, 2016 | 58187000 | 1114000 |
| Sunday, January 1, 2017 | 79479000 | 25573000 |
| Monday, January 1, 2018 | 94123000 | 6000000 |
| Tuesday, January 1, 2019 | 114249000 | 38845000 |
| Wednesday, January 1, 2020 | 131328000 | 50523000 |
| Friday, January 1, 2021 | 150991000 | 75463000 |
| Saturday, January 1, 2022 | 206997000 | 105767000 |
| Sunday, January 1, 2023 | 255000000 | 167512000 |
| Monday, January 1, 2024 | 312068000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. This chart offers a fascinating glimpse into the cost of revenue trends for Incyte Corporation and Xenon Pharmaceuticals Inc. over the past decade. From 2014 to 2023, Incyte Corporation's cost of revenue surged by an impressive 8,400%, reflecting its aggressive growth strategy and increased production capabilities. In contrast, Xenon Pharmaceuticals Inc. experienced a more modest increase of approximately 2,700%, indicating a steady yet cautious expansion.
These trends underscore the diverse strategies employed by biotech companies in navigating the competitive market.
Cost Insights: Breaking Down Eli Lilly and Company and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Incyte Corporation
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Incyte Corporation
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Dyne Therapeutics, Inc.
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Vericel Corporation's Expenses